Caveolin expression and activation in retroperitoneal and subcutaneous adipocytes: Influence of a high-fat diet

Journal of Cellular Physiology

Volumn 225, Issue 1, 2010, Pages 206-213

  Gómez Ruiz, Ana ^a   Milagro, Fermín I ^a   Campión, Javier ^a   Martínez, J Alfredo ^a   De Miguel, Carlos ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN; CAVEOLIN 1; CAVEOLIN 2; GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE INACTIVATION; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; RETROPERITONEUM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SUBCUTANEOUS FAT;

ADIPOCYTES; ANIMALS; BODY COMPOSITION; BODY WEIGHT; CAVEOLINS; DIET; DIETARY FATS; ENERGY METABOLISM; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; INTRA-ABDOMINAL FAT; MALE; PROTEIN ISOFORMS; RATS; RATS, WISTAR; RECEPTOR, INSULIN; SUBCUTANEOUS FAT;

RATTUS;

EID: 77956539102     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22241     Document Type: Article

References (51)

1. Ahima RS, Flier JS. 2000. Adipose tissue as an endocrine organ. Trends Endocrinol Metab 11:327-332.
2. Bluher M. 2009. Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes 117:241-250.
3. Boden G, Hoeldtke RD. 2003. Nerves, fat, and insulin resistance. N Engl J Med 349:1966-1967.
4. Campión J, Martínez JA. 2004. Ketoconazole, an antifungal agent, protects against adiposity induced by a cafeteria diet. Horm Metab Res 36:485-491.
5. Campión J, Milagro FI, Fernández D, Martínez JA. 2006. Differential gene expression and adiposity reduction induced by ascorbic acid supplementation in a cafeteria model of obesity. J Physiol Biochem 62:71-80.
6. Cohen AW, Combs TP, Scherer PE, Lisanti MP. 2003. Role of caveolin and caveolae in insulin signaling and diabetes. Am J Physiol Endocrinol Metab 285:E1151-E1160. (Pubitemid 37464364)
7. Compher C, Badellino KO. 2008. Obesity and inflammation: Lessons from bariatric surgery. J Parenter Enteral Nutr 32:645-647.
8. Deregowski V, Delhalle S, Benoit V, Bours V, Merville MP. 2002. Identification of cytokine-induced nuclear factor-kappaB target genes in ovarian and breast cancer cells. Biochem Pharmacol 64:873-881.
9. Ebert BL, Gleadle JM, O'Rourke JF, Bartlett SM, Poulton J, Ratcliffe PJ. 1996. Isoenzyme-specific regulation of genes involved in energy metabolism by hypoxia: Similarities with the regulation of erythropoietin. Biochem J 313:809-814.
10. Eriksson JW, Smith U, Waagstein F, Wysocki M, Jansson PA. 1999. Glucose turnover and adipose tissue lipolysis are insulin-resistant in healthy relatives of type 2 diabetes patients: Is cellular insulin resistance a secondary phenomenon? Diabetes 48:1572-1578.
11. Fabris R, Nisoli E, Lombardi AM, Tonello C, Serra R, Granzotto M, Cusin I, Rohner-Jeanrenaud F, Federspil G, Carruba MO, Vettor R. 2001. Preferential channeling of energy fuels toward fat rather than muscle during high free fatty acid availability in rats. Diabetes 50:601-608.
12. Fan JY, Carpentier JL, van Obberghen E, Grunfeld C, Gorden P, Orci L. 1983. Morphological changes of the 3T3-L1 fibroblast plasma membrane upon differentiation to the adipocyte form. J Cell Sci 61:219-230.
13. Fischer-Posovszky P, Wabitsch M, Hochberg Z. 2007. Endocrinology of adipose tissue - An update. Horm Metab Res 39:314-321.
14. Fortuño A, Rodríguez A, Gómez-Ambrosi J, Fruhbeck G, Díez J. 2003. Adipose tissue as an endocrine organ: Role of leptin and adiponectin in the pathogenesis of cardiovascular diseases. J Physiol Biochem 59:51-60. (Pubitemid 36889354)
15. García-Díaz DF, Campión J, Milagro FI, Lomba A, Marzo F, Martínez JA. 2007. Chronic mild stress induces variations in locomotive behavior and metabolic rates in high fat fed rats. J Physiol Biochem 63:337-346.
16. Gesta S, Tseng YH, Kahn CR. 2007. Developmental origin of fat: Tracking obesity to its source. Cell 131:242-256.
17. Giorgino F, Laviola L, Eriksson JW. 2005. Regional differences of insulin action in adipose tissue: Insights from in vivo and in vitro studies. Acta Physiol Scand 183:13-30.
18. Gómez-Ruiz A, de Miguel C, Campión J, Martínez JA, Milagro FI. 2009. Time-dependent regulation of muscle caveolin activation and insulin signalling in response to high-fat diet. FEBS Lett 583:3259-3264.
19. Gustavsson J, Parpal S, Karlsson M, Ramsing C, Thorn H, Borg M, Lindroth M, Peterson KH, Magnusson KE, Stralfors P. 1999. Localization of the insulin receptor in caveolae of adipocyte plasma membrane. FASEB J 13:1961-1971.
20. Hamdy O, Porramatikul S, Al-Ozairi E. 2006. Metabolic obesity: The paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2:367-373. (Pubitemid 44734225)
21. Harman-Boehm I, Bluher M, Redel H, Sion-Vardy N, Ovadia S, Avinoach E, Shai I, Kloting N, Stumvoll M, Bashan N, Rudich A. 2007. Macrophage infiltration into omental versus subcutaneous fat across different populations: Effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab 92:2240-2247.
22. Jobgen W, Fu WJ, Gao H, Li P, Meininger CJ, Smith SB, Spencer TE, Wu G. 2009. High fat feeding and dietary L-arginine supplementation differentially regulate gene expression in rat white adipose tissue. Amino Acids 37:187-198.
23. Khan AH, Pessin JE. 2002. Insulin regulation of glucose uptake: A complex interplay of intracellular signalling pathways. Diabetologia 45:1475-1483.
24. Laviola L, Perrini S, Cignarelli A, Natalicchio A, Leonardini A, De Stefano F, Cuscito M, De Fazio M, Memeo V, Neri V, Cignarelli M, Giorgino R, Giorgino F. 2006. Insulin signaling in human visceral and subcutaneous adipose tissue in vivo. Diabetes 55:952-961.
25. López IP, Milagro FI, Martí A, Moreno-Aliaga MJ, Martínez JA, De Miguel C. 2004. Gene expression changes in rat white adipose tissue after a high-fat diet determined by differential display. Biochem Biophys Res Commun 318:234-239.
26. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. 1985. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419. (Pubitemid 15018832)
27. Milagro FI, Campión J, Martínez JA. 2006. Weight gain induced by high-fat feeding involves increased liver oxidative stress. Obesity 14:1118-1123.
28. Nystrom FH, Chen H, Cong LN, Li Y, Quon MJ. 1999. Caveolin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected Cos-7 cells and rat adipose cells. Mol Endocrinol 13:2013-2024.
29. Oh YS, Cho KA, Ryu SJ, Khil LY, Jun HS, Yoon JW, Park SC. 2006. Regulation of insulin response in skeletal muscle cell by caveolin status. J Cell Biochem 99:747-758.
30. Pickavance LC, Brand CL, Wassermann K, Wilding JP. 2005. The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats. Br J Pharmacol 144:308-316. (Pubitemid 40313676)
31. Roth J, Qiang X, Marban SL, Redelt H, Lowell BC. 2004. The obesity pandemic: Where have we been and where are we going? Obes Res 12:88S-101S.
32. Royer C, Lachuer J, Crouzoulon G, Roux J, Peyronnet J, Mamet J, Pequignot J, Dalmaz Y. 2000. Effects of gestational hypoxia on mRNA levels of Glut3 and Glut4 transporters, hypoxia inducible factor-1 and thyroid hormone receptors in developing rat brain. Brain Res 856:119-128.
33. Scherer PE, Lisanti MP, Baldini G, Sargiacomo M, Mastick CC, Lodish HF. 1994. Induction of caveolin during adipogenesis and association of GLUT4 with caveolin-rich vesicles. J Cell Biol 127:1233-1243.
34. Schwab W, Galbiati F, Volonte D, Hempel U, Wenzel KW, Funk RH, Lisanti MP, Kasper M. 1999. Characterisation of caveolins from cartilage: Expression of caveolin-1, -2 and -3 in chondrocytes and in alginate cell culture of the rat tibia. Histochem Cell Biol 112:41-49.
35. Schwencke C, Braun-Dullaeus RC, Wunderlich C, Strasser RH. 2006. Caveolae and caveolin in transmembrane signaling: Implications for human disease. Cardiovasc Res 70:42-49.
36. Sharma PM, Egawa K, Huang Y, Martin JL, Huvar I, Boss GR, Olefsky JM. 1998. Inhibition of phosphatidylinositol 3-kinase activity by adenovirus-mediated gene transfer and its effect on insulin action. J Biol Chem 273:18528-18537. (Pubitemid 28334782)
37. Shin T, Kim H, Jin JK, Moon C, Ahn M, Tanuma N, Matsumoto Y. 2005. Expression of caveolin-1, -2, and -3 in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis. J Neuroimmunol 165:11-20.
38. Thomàs-Moyà E, Gianotti M, Proenza AM, Lladó I. 2007. Paraoxonase 1 response to a high-fat diet: Gender differences in the factors involved. Mol Med 13:203-209.
39. Tong Q, Dalgin G, Xu H, Ting CN, Leiden JM, Hotamisligil GS. 2000. Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 290:134-138.
40. Tran TT, Yamamoto Y, Gesta S, Kahn CR. 2008. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab 7:410-420. (Pubitemid 351598027)
41. Trayhurn P, Wood IS. 2004. Adipokines: Inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 92:347-355.
42. Van Deurs B, Roepstorff K, Hommelgaard AM, Sandvig K. 2003. Caveolae: Anchored, multifunctional platforms in the lipid ocean. Trends Cell Biol 13:92-100.
43. Van Harmelen V, Reynisdottir S, Eriksson P, Thorne A, Hoffstedt J, Lonnqvist F, Arner P. 1998. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47:913-917. (Pubitemid 28255665)
44. Virtanen KA, Lonnroth P, Parkkola R, Peltoniemi P, Asola M, Viljanen T, Tolvanen T, Knuuti J, Ronnemaa T, Huupponen R, Nuutila P. 2002. Glucose uptake and perfusion in subcutaneous and visceral adipose tissue during insulin stimulation in nonobese and obese humans. J Clin Endocrinol Metab 87:3902-3910.
45. Virtanen KA, Hallsten K, Parkkola R, Janatuinen T, Lonnqvist F, Viljanen T, Ronnemaa T, Knuuti J, Huupponen R, Lonnroth P, Nuutila P. 2003. Differential effects of rosiglitazone and metformin on adipose tissue distribution and glucose uptake in type 2 diabetic subjects. Diabetes 52:283-290.
46. Williams TM, Lisanti MP. 2004a. The Caveolin genes: From cell biology to medicine. Ann Med 36:584-595.
47. Williams TM, Lisanti MP. 2004b. The caveolin proteins. Genome Biol 5:214.
48. Wood IS, de Heredia FP, Wang B, Trayhurn P. 2009. Cellular hypoxia and adipose tissue dysfunction in obesity. Proc Nutr Soc 68:370-377.
49. Yamada E. 1955. The fine structure of the gall bladder epithelium of the mouse. J Biophys Biochem Cytol 1:445-458.
50. Yamamoto M, Toya Y, Schwencke C, Lisanti MP, Myers MG, Jr., Ishikawa Y. 1998. Caveolin is an activator of insulin receptor signaling. J Biol Chem 273:26962-26968. (Pubitemid 28471718)
51. Yenush L, White MF. 1997. The IRS-signalling system during insulin and cytokine action. BioEssays 19:491-500.